L
Luis Lasalvia
Researcher at Siemens
Publications - 24
Citations - 310
Luis Lasalvia is an academic researcher from Siemens. The author has contributed to research in topics: Ejection fraction & Cost effectiveness. The author has an hindex of 7, co-authored 24 publications receiving 220 citations.
Papers
More filters
Journal ArticleDOI
Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT Study.
Juan Acosta,Juan Fernández-Armenta,Roger Borràs,Ignasi Anguera,Felipe Bisbal,Julio Martí-Almor,José María Tolosana,Diego Penela,D. Andreu,David Soto-Iglesias,Reinder Evertz,Maria Matiello,Concepción Alonso,Roger Villuendas,Teresa M. de Caralt,Rosario J. Perea,José T. Ortiz,Xavier Bosch,Luis Serra,Xavier Planes,Andreas Greiser,Okan Ekinci,Luis Lasalvia,Lluís Mont,Antonio Berruezo +24 more
TL;DR: The presence, extension, heterogeneity, and qualitative distribution of BZ tissue of myocardial scar independently predict appropriate ICD therapies and SCD in CRT patients.
Journal ArticleDOI
Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension.
Brett E. Fenster,Luis Lasalvia,Joyce D. Schroeder,Jamey Smyser,Lori J. Silveira,J. Kern Buckner,Kevin K. Brown +6 more
TL;DR: Serum Gal-3 levels are associated with multiple indices of RV function and morphology, and may represent a novel biomarker for RV remodeling and associated ECM turnover in PAH.
Journal ArticleDOI
Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.
María Dolores Giráldez,Juan José Lozano,Miriam Cuatrecasas,Virginia Alonso-Espinaco,Joan Maurel,Maribel Marmol,Carlos Horndler,Javier Ortego,Vicente Alonso,Pilar Escudero,Gina Ramírez,Christoph Petry,Luis Lasalvia,Kerstin Bohmann,Ralph M. Wirtz,Aurea Mira,Antoni Castells +16 more
TL;DR: Identification of a new gene‐expression signature associated with a high probability of tumor recurrence in patients with Stages II and III colon cancer receiving adjuvant 5FU‐based chemotherapy, and its combination in a robust, easy‐to‐use and reliable algorithm may contribute to tailor treatment and surveillance strategies.
Journal ArticleDOI
Cystatin C: a potential biomarker for pulmonary arterial hypertension.
Brett E. Fenster,Luis Lasalvia,Joyce D. Schroeder,Jamey Smyser,Lori J. Silveira,J. Kern Buckner,Kevin K. Brown +6 more
TL;DR: Cystatin C, a novel marker of renal function, predicts left heart failure and cardiovascular mortality and the hypothesis that serum CysC levels correlate with right ventricular morphology, function and pressure in pulmonary arterial hypertension was tested.
Journal ArticleDOI
Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients
TL;DR: The use of the ELF test with or without a confirmation LSM are cost-effective options compared to a single liver biopsy for testing liver fibrosis in HCV and ALD patients in Spain.